Healthcare & Life Sciences News and Articles

Google News – Pharmaceuticals External News

ANI Pharmaceuticals stock hits 52-week low at 70.03 USD - Investing.com

news.google.com · 09 Sep 2026

Google News – Pharmaceuticals External News

The Transition to Home: Why Confidence is Critical to Patient Success - Pharmaceutical Commerce

news.google.com · 09 Sep 2026

Google News – Oncology External News

Urogen Pharma: Upside After Bladder Cancer Launch (NASDAQ:URGN) - Seeking Alpha

news.google.com · 09 Sep 2026

Google News – Pharmaceuticals External News

1cBio and Lee's Pharmaceutical Holdings Limited Enter into Exclusive Licensing Agreement to Develop and Commercialize 1cBio's PARP1 Inhibitor OC-3 for Oncology in Greater China and Southeast Asia - BioSpace

news.google.com · 09 Sep 2026

Google News – Pharmaceuticals External News

Kaplan Fox Deadline Alert: ARS Pharmaceuticals Inc. (NASDAQ: SPRY) Investors Have Until October 5, 2026 to Seek a Lead Plaintiff Role - NewMediaWire

news.google.com · 09 Sep 2026

Google News – Biotech Funding External News

GV-backed Encoded gains $275M to advance Dravet drug, scale genetic med manufacturing - Fierce Biotech

news.google.com · 09 Sep 2026

Google News – Pharmaceuticals External News

Recursion Pharmaceuticals Stock Short Interest Falls to 34.79% - Quiver Quantitative

news.google.com · 09 Sep 2026

Google News – FDA (biotech/pharma) External News

Pharmalittle: We're reading about an AstraZeneca COPD win, the FDA filling key jobs, and more - STAT

news.google.com · 09 Sep 2026

Google News – Pharmaceuticals External News

ANI Pharmaceuticals (NASDAQ:ANIP) Earns Outperform Rating from Analysts at Leerink Partners - MarketBeat

news.google.com · 09 Sep 2026

Industry News External News

GLP-1 boom pushes pharma companies deeper into wellness, nutraceuticals - BusinessLine

news.google.com · 09 Sep 2026

Google News – Biopharma External News

Quantum BioPharma receives FDA clearance for MS phase 2 trial By Investing.com - Investing.com India

news.google.com · 09 Sep 2026

Google News – Biopharma External News

Celcuity at citigroup’s biopharma back to school summit: launch begins By Investing.com - Investing.com India

news.google.com · 09 Sep 2026

Google News – FDA (biotech/pharma) External News

FDA solidifies CDER, CBER leadership posts as commissioner confirmation awaits - fiercepharma.com

news.google.com · 09 Sep 2026

Google News – Biopharma External News

Propanc Biopharma plans phase 1b cancer trial in Australia - Investing.com

news.google.com · 09 Sep 2026

Google News – Biopharma External News

Can-Fite Biopharma Reports Clinical Improvement with Namodenoson in Decompensated Cirrhosis and Successful Bridging to Liver Transplantation - marketscreener.com

news.google.com · 09 Sep 2026

News & Articles

The Frontline Signal: Turning Daily Friction Into Better Healthcare Hiring

The Digital Health Interpreter: Making Technology Usable in Care

The Pitt is up for 25 Emmys - but the show's biggest fans are real-life doctors

From Roster to Resilience: Building a Workforce Risk Register

The Protocol-to-Workflow Specialist: A Career Emerging in Clinical Research

Jury should decide if university’s hiring process was tainted by diversity goals, court rules

Running costs of vaccine damage scheme more than double amount paid to victims

CMS expands TAVR Medicare coverage to asymptomatic patients

Stryker stock falls on slower peripheral vascular, hip sales

Veterans Affairs taps Amwell for telehealth revamp - Healthcare Dive

8 stories on the healthcare affordability crunch

Campaigners hold vigil as stroke unit closes

Epidural Kit Correction: Medical Action Industries Issues Correction for Epidural Kits Containing Spectra Medical Devices Lidocaine Ampules

UK needs new laws for AI in healthcare, says watchdog

Migraines and acne among five more conditions pharmacists can treat

Maternal Mental Health Policy

4 questions about the FDA’s approach to generative AI

Presidential dialogue on high-threat pathogens

5 takeaways from Oura’s IPO filing

Contractors will bear repair costs for lift defects at Queen Mary Hospital, Hong Kong development chief says

ANI Pharmaceuticals stock hits 52-week low at 70.03 USD - Investing.com

The Transition to Home: Why Confidence is Critical to Patient Success - Pharmaceutical Commerce

Urogen Pharma: Upside After Bladder Cancer Launch (NASDAQ:URGN) - Seeking Alpha

1cBio and Lee's Pharmaceutical Holdings Limited Enter into Exclusive Licensing Agreement to Develop and Commercialize 1cBio's PARP1 Inhibitor OC-3 for Oncology in Greater China and Southeast Asia - BioSpace

Kaplan Fox Deadline Alert: ARS Pharmaceuticals Inc. (NASDAQ: SPRY) Investors Have Until October 5, 2026 to Seek a Lead Plaintiff Role - NewMediaWire

GV-backed Encoded gains $275M to advance Dravet drug, scale genetic med manufacturing - Fierce Biotech

Recursion Pharmaceuticals Stock Short Interest Falls to 34.79% - Quiver Quantitative

Pharmalittle: We're reading about an AstraZeneca COPD win, the FDA filling key jobs, and more - STAT

ANI Pharmaceuticals (NASDAQ:ANIP) Earns Outperform Rating from Analysts at Leerink Partners - MarketBeat

GLP-1 boom pushes pharma companies deeper into wellness, nutraceuticals - BusinessLine

Quantum BioPharma receives FDA clearance for MS phase 2 trial By Investing.com - Investing.com India

Celcuity at citigroup’s biopharma back to school summit: launch begins By Investing.com - Investing.com India

FDA solidifies CDER, CBER leadership posts as commissioner confirmation awaits - fiercepharma.com

Propanc Biopharma plans phase 1b cancer trial in Australia - Investing.com

Can-Fite Biopharma Reports Clinical Improvement with Namodenoson in Decompensated Cirrhosis and Successful Bridging to Liver Transplantation - marketscreener.com